The metabolic regulation of the immune system is important in the pathogenesis and progression of numerous diseases, such as cancers, autoimmune diseases and metabolic diseases.
However, interconnections between metabolic pathways are notoriously complex, limiting researchers’ ability to develop effective therapeutic strategies. Therefore, deeper real-time analysis is needed to inform interventions and improve immune cell function.
This application overview explores how real-time metabolic analysis can reveal critical pathways and targets for modulating immune responses, optimizing cell therapy approaches and offering a comprehensive understanding of immune cell behavior in different environments.
Download this application overview to discover:
- How real-time measurements drive better insights into immune cell metabolism
- Key techniques for linking metabolic processes with immune cell function
- Strategies for applying metabolic insights to improve therapeutic outcomes
Live Cell Metabolic Analysis
for Immunology Research
Agilent Seahorse XF technology
Immune cells are able to sense a variety of stimulus and signals from their environment and
integrate those signals to tune intracellular processes and functions to deliver an integrated
immune response. Analytical approaches such as immune cell marker expression assays, cytokine
release assays, and pathway profiling provide a conventional categorization of immune cells,
especially after the cell is committed to a particular lineage or activation state. However, pathway
intervention and modulation to control immune cell function requires a more comprehensive view
of immune cell fate and function, including an understanding of the upstream drivers of immune
cell processes. Metabolic programs are critical determinants of immune cell outcomes.
Agilent Seahorse XF technology provides kinetic, functional metabolic measurements for a
more direct measure of immune cell processes as they are happening, in real time. Metabolic
programs are upstream determinants of immune cell outcomes. Immune cell processes—including
activation, proliferation, and memory development—are all driven by metabolic reprogramming,
which can be modulated to enhance performance. Metabolic analysis not only delivers real-time
kinetics but provides a rich set of pathway targets to modulate immune cell biology.
Direct the Immune System by Modulating the
Metabolic Pathways That Regulate Cell Fate
and Function
Figure 1. Measurement of immune cell metabolic
phenotypes, illustrating a relationship between
Glycolysis/OXPHOS Ratio and cell fate, fitness,
and function.
T cell fate
Naïve
Effector
Glycolysis Glycolysis/OXPHOS ratio OXPHOS Time
Exhaustion
Intervention
T cell fitness
T cell fate
T cell
activation
Memory
Chronic
3
Agilent Seahorse XF technology provides real-time measurement of cellular bioenergetics.
Bioenergetic parameters such as mitochondrial activity, glycolysis, and ATP production rates
deliver information about the immediate-to-early functions of immune cells for a more complete
understanding of immune cell function that can be modulated to enhance or predict performance.
Agilent Seahorse XF Cell Analysis
Solutions for Immunology Research
Generate real-time functional data from live cells
Immunology researchers are using Agilent Seahorse XF cell analysis technology to investigate:
– Immune cell life cycle, activation, and lineage commitment
– Memory phenotyping, fitness, exhaustion, and ability to sustain function
– Metabolic fuels requirements
– Metabolic signaling, pathways, checkpoints, and blockades
– Host-pathogen metabolism in infectious disease
State-of-the-art
data analytics tools
Real-time
calculation
of results
Tested
kits, media,
and reagents
Label-free
pH and
O2 sensor
cartridge
More relevant
injection ports
for real-time
modulation
Live-cell
analysis
with 2D and 3D
plate options
Find out more about the Agilent Seahorse XF Pro, click here.
Minutes Minutes
CD28, TCRζ 4-1BB, TCRζ
Minutes
Day 0 Day 7 Day 21
Oligomycin Oligomycin Oligomycin
FCCP FCCP FCCP
Rotenone Rotenone Rotenone
+ Antimycin A + Antimycin A + Antimycin A
OCR (pmol/min)
OCR (pmol/min)
OCR (pmol/min)
2500 2500 2500
2000 2000 2000
1500 1500 1500
1000 1000 1000
500 500 500
0 0 0
0 50 100 150 0 50 100 150 0 50 100 150
4
Discover strategies to perturbate pathways and control immune cell response to advance
cell therapy developments
The goal of immune cell-based therapies is to enhance the performance
of native immune cells by expanding or modifying immune cells to alter relevant
signaling pathways that results in change in the cellular function. XF analysis
provides critical measurements of live cells in real time, revealing the functional
outcome of modulation strategies. Discover how modulation of immune cell
responses via signaling, checkpoint blockade, or pathway perturbation is
"functionalized" through changes in metabolic programming.
Spare respiratory capacity (SRC) is a reliable measure of mitochondrial function representing the ability of the cells to
increase mitochondrial energy production if required. For expanded CAR T cells, an increase in SRC correlates strongly with
T cell memory or T stem cell memory phenotypes.
Kawalekar et al. used the Seahorse XF assays to show that the choice of CAR signaling domain determines the bioenergetic
phenotype of CD8+ CAR T cells postantigen stimulation. Over a 21-day period, CAR T cells containing the 4-1BB signaling
costimulatory domain progressed towards exhibiting a greater SRC, which culminated in enhanced in vitro persistence and
increased central memory differentiation relative to CAR T cells containing the CD28-signaling costimulatory domain.
Metabolic Analysis Reveals a Rich Set of Pathway
Targets to Advance New Therapeutic Opportunities
in Immuno-Oncology
Figure 2. T cell engineering and bioenergetics
affects "T cell fate" favoring toward effector or
memory population.
Figure 3. Adapted from Kawalekar, O. et al. Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and
Impacts Memory Development in CAR T Cells. Immunity 2016, 44(2), 380–90.
Metabolic analysis advances adoptive immunotherapy development by revealing a critical metabolic
link between CAR T coreceptors and effector versus memory cell response
Cell Fate
Tuning
CAR
Engineering
CAR
Engineering
CD28, TCRζ 4-1BB TCRζ
Immune Memory
Persistence
Central Memory
Oxidative Phosphorylation
Tumor Killing
Effector memory
Aerobic glycolysis
T cell
Cell Fate
Tuning
5
Seahorse XF assays were used in studies by Zandberg, D. et al. to show that oxidative metabolism is upregulated as tumors
become resistant to anti-PD-1 blockade. They demonstrated that the metabolic status of the tumor microenvironment can
be predictive of tumor response to anti-PD-1 therapy.
Notarangelo et al used Seahorse XF technology to show that
tumor derived d-2-hydroxyglutarate (D-2HG) leads to altered
metabolic poise in CD8+ T cells with increased reliance on
oxidative phosphorylation for ATP generation, which results in
impaired proliferation, cytokine production, and cytotoxicity.
Figure 4. Adapted from Zandberg, D. et al. Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell
carcinoma of the head and neck. J ImmunoTher Cancer 2021, 9(5), e002088.
Figure 5. Adapted from Notarangelo, G. et al. Oncometabolite d-2HG alters T cell metabolism to impair CD8+ T cell function.
Science 2022, 377(6614), 1519–1529.
Figure 6. Adapted from Li, L. et al. Loss of metabolic fitness drives tumor resistance after CAR-NK cell
therapy and can be overcome by cytokine engineering. Science Advances 2023, 9, eadd6997
Monitor metabolic changes in tumor cells to better characterize the tumor microenvironment
and exploit checkpoint therapies
Assess T cell bioenergetic poise for unique insights into cellular phenotype and function
Evaluate the impact of metabolic fitness on immune cell function
Li et al. used Seahorse XF technology to show that engineering CAR19 NK cells to express interleukin 15 (IL-15) results in
enhanced metabolic fitness with improved glycolytic activity compared to controls. Their study showed that the antitumor
effects of CAR NK cells can be improved by increasing their metabolic fitness.
6
Functional Seahorse XF measurements provide insights into the critical factors affecting
immune cell response, fate, and function
Metabolism as an indicator of phenotype and inflammatory function in macrophages
Metabolic measurements provide a sensitive indication of how immune cells
respond under various conditions to meet the integrated and multifaceted demands
associated with immune responses. Researchers are applying Seahorse XF
technology to investigate questions relating to inflammation, autoimmunity, and
immunosuppression, along with substrate dependencies and immunosuppressive
effect of the tumor microenvironment.
Both pro‐inflammatory (M1) and anti‐inflammatory (M2) polarization of
macrophages causes an increase in the ATP production rate, but energy metabolism
responds in dramatically different ways. The anti‐inflammatory M2 phenotype is
strongly characterized by oxidative phosphorylation, whereas macrophages of
the pro‐inflammatory M1 phenotype increase glycolysis and redirect their aerobic
metabolism towards the generation of reactive oxygen species and pro‐inflammatory
metabolites such as succinate and itaconate.
Real-Time, Quantitative Measurements Provide a
Comprehensive Picture of Immune Cell Function
Figure 7. The Agilent Seahorse XF Real-Time ATP rate assay reveals that
macrophage polarization is driven by two distinct cellular metabolic programs. From
Divakaruni et al. (2018) Cell Metabolism and Desousa et al. (2023) EMBO Reports.
7
Seahorse XF technology provides insights into essential pathways, signaling, and nutrient
requirements for antitumor immune responses relevant to the tumor microenvironment
Metabolic measurements provide a sensitive indication of how immune cells
respond under various conditions to meet the integrated and multifaceted demands
associated with immune responses. Researchers are applying Seahorse XF
technology to investigate questions relating to inflammation, autoimmunity, and
immunosuppression, along with substrate dependencies and immunosuppressive
effect of the tumor microenvironment.
Seahorse XF assays were used by Poznanski et al., to generate insights into the mechanisms of NK cell dysfunction in the
tumor microenvironment (TME). The study showed that reprogramming NK cells to increase their metabolic substrate
flexibility resulted in sustained metabolic fitness and increased antitumor activity in the hostile TME.
Figure 8. Targeting oxidative stress restores natural killer cell metabolism and
function in the immunosuppressive tumor microenvironment Adapted from
Pozanski, S. et al. Metabolic flexibility determines human NK cell functional
fate in the tumor microenvironment. Cell Metab 2021, 33, 1205–1220.
8
Real-time analysis of immune cell activation offers insights into metabolic requirements,
signaling, pathways, and checkpoints
Measure metabolism as an indicator of immune cell type, function, and lineage commitment
Metabolic phenotyping provides insights into immune cell function
Activation, proliferation, engagement of effector functions, and return to homeostasis are all crucial aspects of the
immune cell life cycle—with lineage and immune cell identity constraining the ability of immune cells to function in
these roles. Seahorse XF technology provides real-time functional measurements for a comprehensive picture of
immune cell function and insights into pathways and targets to modulate immune cell responses.
The XF T cell Metabolic Profiling kit reveals the complete bioenergetic profile, including glycolytic and mitochondrial
bioenenergetic activity, metabolic poise as well as mitochondrial bioenergetic capacity. It provides a unique insight into
cellular phenotype and function at different cellular differentiation states. Naïve T cells have a quiescent phenotype with
a low reliance on glycolysis, upon activation by antigen encounter there is an increase in glycolytic activity. When the
infection is resolved a small number of these cells generate a memory population and glycolytic activity decreases again.
Any Change in Immune Cell Function Requires
a Change in Bioenergetics
Redirection of glucose metabolismDCA
T cell receptor signaling LcK1 inhibitor Cell signaling pathway,
GSK-3beta inhibitor
Figure 9.The Agilent Seahorse XF Hu T Cell Activation Assay reveals metabolic and signaling requirements critical for
T cell activation, allowing you to interrogate the effect of T cell modulators. From Kam et al. Determining the Metabolic
Consequences of Pharmacological Modulation of T Cell Activation. Agilent Technologies Poster, ASGCT, 2020.
Figure 10. T cells undergo major metabolic changes upon activation, switching to glycolysis to support effector functions and
rapid cell growth. Human panT cells were activated with anti CD3/CD28 for 3 days and expanded after in cell culture media. The
XF T Cell Metabolic Fitness Assay of naive T cells (before activation) and T cells activated and expanded for 6 days (Effector)
and 15 days (Memory) was performed using the Agilent Seahorse XFPro Analyzer. Agilent Technologies unpublished data.
0
100
200
300
PER (%)
Time (min)
B
0 20 40 60 80 100 120
CD3/CD28 Activator 2-DG
Control
Vehicle
0
100
200
300
PER (%)
Time (min)
A
0 20 40 60 80 100 120
CD3/CD28 Activator 2-DG Control
Vehicle
0
100
200
300
PER (%)
Time (min)
A
0 20 40 60 80 100 120
CD3/CD28 Activator 2-DG Control
Vehicle
0
100
200
300
PER (%)
Time (min)
B
0 20 40 60 80 100 120
CD3/CD28 Activator 2-DG
Control
Vehicle
0
100
200
300
PER (%)
Time (min)
A
0 20 40 60 80 100 120
CD3/CD28 Activator 2-DG Control
Vehicle
0
100
200
300
PER (%)
Time (min)
A
0 20 40 60 80 100 120
CD3/CD28 Activator 2-DG Control
Vehicle
0
100
200
300
PER (%)
Time (min)
B
0 20 40 60 80 100 120
CD3/CD28 Activator 2-DG
Control
Vehicle
0
100
200
300
PER (%)
Time (min)
A
0 20 40 60 80 100 120
CD3/CD28 Activator 2-DG Control
Vehicle
0
100
200
300
PER (%)
Time (min)
A
0 20 40 60 80 100 120
CD3/CD28 Activator 2-DG Control
Vehicle
Lck inhibitor
TWS119
Naive
Naive
glycoATP production rate
(pmol/min/1x105 cells)
%ATP from glycolysis
OCR (pmol/min/1x105 cells
1200
1000
800
600
100
80
60
40
20
0
80
60
40
20
0
400
300
200
100
0
0 20 40 60
Time (minutes)
Naive
Effector
Memory
80 Effector
Effector
Memory
Memory
Oligomycin A
Rotenone/
BAM15 Antimycin A
9
Generate Powerful Insights into
Host-Pathogen Metabolic Response
Figure 11. Norovirus infected murine macrophages increase their dependence on glycolysis for ATP production. Reproduced
under the creative commons license 4.0 from Passalacqua, K. et al. Glycolysis Is an Intrinsic Factor for Optimal Replication
of a Norovirus. mBio 2019, 10(2), 02175–18. https://creativecommons.org/licenses/by/4.0/
Pathogens commonly target host cellular metabolic pathways to establish optimal conditions for
infection. The host response may include large-scale changes in cellular metabolism, including hijacking
central carbon metabolic pathways and changing mitochondrial function. A cascade of signaling
networks and checkpoints also triggers the innate immune response for combating infection. Seahorse
XF technology provides critical functional measurements for a comprehensive, systems-level view of the
host response, providing insights into potential therapeutic targets.
The Seahorse XF Real-Time ATP rate assay revealed that norovirus infection of murine macrophage cells results in an
increase in overall ATP production rate, with increases in both glycolysis and OXPHOS but with an overall reprogramming to
a more glycolytic phenotype, suggesting a critical role of host-glycolytic activity to sustain initial viral infection
Find out more about how Agilent Seahorse XF can help you investigate immune metabolism at our dedicated webpage here. ATP production rate (pmol/min) Mitochondrial-ATP Production rate (pmol/min)
Glycolysis-ATP production rate
(pmol/min)
mitoATP production rate/glycoATP
(pmol/min)
1200
1000
800
600
400
200
0
800
600
400
200
mock 0
0 100
MNV
+2DG
MNV
aerobic energetic
quiescent glycolytic
mock
+2DG mock
200 300 400
mock
1
10
72%
28%
66%
34%
81% 81%
19% 19%
RAW 264.7
ATP production
RAW 264.7 energetic map XF ATP rate index
RAW 264.7
Mitochondrial-ATP
Glycolysis-ATP
MNV MNV
***
ns
mock
+2DG
mock MNV +2DG
+2DG
MNV
+2DG
10
XF T Cell Metabolic Profiling assays: Customized assays for cell therapeutics development
With optimized reagents for different T cell and NK cell populations, these assays provide robust bioenergetic parameters
linked to critical attributes for antitumor properties: cell persistence and metabolic fitness.
A comprehensive view of cellular bioengergetics
Optimized Assays for Measuring Immunometabolism
Part number 103772-100 (XF Pro /XFe96) and 103771-100 (XF HS Mini and XFp)
– Suitable for evaluation of construct design, engineering
strategies, starting material selection, or metabolic
conditioning during in vitro cell expansion
– Applicable for use in assessing the capacity of T cells
and NK cells to maintain metabolic fitness in tumor
microenvironments
– Includes BAM15 an improved uncoupler for more
consistent and accurate measurements of T cell and
NK cell mitochondrial function
– Provides a comprehensive view of T cell and NK cell
metabolism, including simultaneous quantification of
both glycolytic and mitochondrial effects activity and
bioenergetic capacity
– Tested for both T cell and NK cell metabolic profiling
11
Agilent Seahorse XF real-time immune cell activation assays deliver a rapid and robust
indicator of activation
Immune cell activation is driven by a rapid switch towards growth-promoting pathways required for cellular proliferation.
Agilent Seahorse XF real time immune cell activation assays enable the detection of activation responses in minutes upon
stimulation, providing insights into immune cell activation, modulation and related metabolic reprogramming,.
T Cell Activation Assay
(Kit part number 103759-100 Macrophage Activation Assay
LPS+IFNy
Neutrophil Activation Assay
Explore Agilent Seahorse XF assay kits here
Immune cell specific:
– Agilent Seahorse XF Hu T cell activation assay
– Agilent Seahorse XF real-time macrophage activation assay
– Agilent Seahorse XF real-time neutrophil activation assay
0
0
50
100
150
200
25 50 75 100
PER (pmol/min)
Time (min)
Activator
or control 2-DG
Baseline Activation Control
Activator
0 50 100 150 200 250
0
100
200
300
400
Time (min)
OCR (pmol/min)
PMA
Human neutrophils
(4 x 104/well)
Vehicle
Rot/
AA
PMA
or Veh.
Time (min)
0 30 60 90 120 150
LPS+IFNy
Control
PER (pmol/min)
0
100
200
300
Learn more:
www.agilent.com/lifesciences/cellanalysis
Buy online:
www.agilent.com/lifesciences/store
Find local Sales and Support in your country:
www.agilent.com/lifesciences/contactus
USA and Canada:
1-800-227-9770
agilentinquiries@agilent.com
Europe
info_agilent@agilent.com
Asia Pacific
inquiry_lsca@agilent.com
For Research Use Only.
Not for use in diagnostic procedures.
RA45427.4037615741
This information is subject to change without notice.
© Agilent Technologies, Inc. 2024
Published in the USA, October 2, 2024
5994-7553EN